Scientia Associate Professor and Program Lead, The George Institute for Global Health, Faculty of Medicine, UNSW Sydney; kidney epidemiology
Sydney, New South Wales
Joined May 2018
- Tweets195
- Following277
- Followers207
- Likes575
Min Jun retweeted
Dr Sradha Kotwal of @UNSW and @georgeinstitute has developed the Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE), aiming to identify an effective drug to prevent CKD progression #KidneyHealthForAll #WorldKidneyDay
Min Jun retweeted
Come work with us!
We have an exciting opening for a biostatistician to join the @georgeinstitute's Renal & Metabolic Division
Great opportunity to work on large-scale cardiorenal randomised trials and routinely collected data
applynow.net.au/jobs/GEORGE6…
DM me for details
Min Jun retweeted
"I wanted to look into an area of research that had the biggest impact on society."
Hear more from Nelson about his work on cardiovascular prevention and his long-term goals for his future work via @heartfoundation: buff.ly/3IaQNjK
Min Jun retweeted
Kidney Function, Albuminuria and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis
buff.ly/3Q22tca
@_jeffreyha @DearbhlaKelly4 @brendonneuen @VladoPerkovic @MinJun____ @badves @georgeinstitute @UNSWMedicine #VisualAbstract
Min Jun retweeted
The Prevalence of #ChronicKidneyDisease in Australian #PrimaryCare: Analysis of a National General Practice Dataset
#VisualAbstract by @jmteakell
kireports.org/article/S2468-…
@MinJun____ @brendonneuen @SradhaKotwal @Badves @davidpeiris @jardine_meg @VladoPerkovic @georgeinstitute
Min Jun retweeted
Improved uptake of SGLT2i in people with CKD has the potential to substantially reduce the incidence of kidney failure in Australia
Implementation now critical to realising these population level benefits
Our new paper #openaccess in @LancetRH_WPac
thelancet.com/journals/lanwp…
Min Jun retweeted
Latest granular data on CKD trends in Australia
CKD is common & increasing year on year
UACR testing remains abysmally low
Major opportunities for early detection & treatment to prevent cardiovascular & kidney disease
Led by @MinJun____ in @KIReports: kireports.org/article/S2468-…
Min Jun retweeted
#ICYMI, check out this #ICESKDT study by @_jeffreyha and team that focused on determining the benefit–risk profile of rivaroxaban versus warfarin for atrial fibrillation in patients with #CKD. pubmed.ncbi.nlm.nih.gov/3749… @ICESOntario @MinJun____ 1/
Min Jun retweeted
Congratulations to @SradhaKotwal for securing @nhmrc funding to test new treatments in people with #ChronicKidneyDisease at trial centres in Australia & other countries.
🔗bit.ly/3KksTE9
Min Jun retweeted
The largest & most comprehensive analysis of the association between SGLT2i, blood pressure variability & cardiorenal outcomes
While SGLT2i reduce BP, they have little to no effect on BP variability
New #openaccess in @JAHA_AHA led by @Fletcher_RA
ahajournals.org/doi/full/10.…
Min Jun retweeted
Sharing this real-world study 🇦🇺🇨🇦showing favorable⚖️ safety🩸& effectiveness of Riva vs Warfarin across broad range of kidney fn with some imp safety data in those with greatly ⏬ kidney fn @MinJun____ @georgeinstitute @UNSWMedicine doi.org/10.1016/j.xkme.2023.…
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia 🇦🇺 and Canada 🇨🇦. @KidneyMed
➡️ bit.ly/3MD9wYl
Min Jun retweeted
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia 🇦🇺 and Canada 🇨🇦. @KidneyMed
➡️ bit.ly/3MD9wYl
Min Jun retweeted
Congratulations to Drs Majed Al Jeraisy, Mohammed Tawhari and @Ahmed_Shaman from @kaimrc_ksa for enrolling their FIRST three patients in TRACK. We welcome Saudi Arabia 🇸🇦 to the TRACK trial.
Min Jun retweeted
Do multifaceted interventions or care bundles reduce #Dialysis catheter related bloodstream infections?
Our researchers @SradhaKotwal and team have published ✍️imp new findings from their @reducction trial today in the @bmj_latest:
▶️bmj.com/content/377/bmj-2021…
Min Jun retweeted
Also provides impt insights into the scale of Hawthorne effect in such evidence implementation studies
Our studies found that as many as 434 million people across Asia could have chronic kidney disease and that it affects women and men differently. Urgent action in Asia is needed to prevent and manage CKD, including equitable policies that address the needs of both women and men
Millions of people with #ChronicKidneyDisease die annually because they cannot afford treatment. New research builds a clearer picture of the growing rates of #KidneyDisease in Asia & how it affects women & men differently. #WorldKidneyDay2022
🔗Read more bit.ly/3vVMTGL
Min Jun retweeted
Fantastic opportunity to work on practice changing trials and big data with collaborative colleagues, and to make a global impact - join us!! @GLDiTanna @MinJun____ @ArnottClare @SradhaKotwal @Badves @alta_schutte
Expressions of Interest invited from biostatisticians across all levels of experience to join our growing Biostatistics team!
Check out details: georgeinstitute.org/careers/…
and connect with @GLDiTanna!
Min Jun retweeted
Fantastic opportunity at my new workplace - join us @UNSWMedicine
This Post is from an account that no longer exists. Learn more
Min Jun retweeted
Congratulations to Sradha Kotwal, winner of the KIDNEY HEALTH AUSTRALIA (KHA) CLINICAL SCIENCE AWARD #ANZSNASM @SradhaKotwal @KidneyHealth @KarenDwyer12
Min Jun retweeted
Congratulations @drmanishasahay for randomising the 100th patient in @TRACK_trial
Top recruiters are
Hospital Tuanku Ja'afar, Seremban
Hospital Raja Permaisuri Bainun, Ipoh
Hospital Canselor Tuanku Muhriz
Hospital Kajang
University of Malaysia Medical Centre 1/3
